Ophthalmic Devices - EMEA

  • EMEA
  • The Ophthalmic Devices market market in the Europe, Middle East, and Africa (in Europe, the Middle East, and Africa) region is anticipated to achieve a revenue of US$14.21bn by 2024.
  • It is projected to exhibit an annual growth rate (CAGR 2024-2029) of 4.60%, leading to a market volume of US$17.79bn by 2029.
  • When compared globally, the United States is expected to generate the highest revenue of US$14,000.00m in 2024.
  • In EMEA, Germany is leading the way in the ophthalmic devices market with innovative technologies and a strong focus on research and development.

Key regions: Germany, Italy, France, Japan, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Ophthalmic Devices market in EMEA is experiencing significant growth and development due to several key factors. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors all contribute to the current state of the market. Customer preferences play a crucial role in driving the growth of the Ophthalmic Devices market in EMEA. With an increasing aging population and a rise in eye-related disorders, there is a growing demand for advanced ophthalmic devices that can diagnose and treat various eye conditions. Customers are seeking devices that offer accurate and efficient diagnosis, as well as innovative solutions for vision correction. Additionally, there is a rising demand for contact lenses and spectacle frames that combine functionality with aesthetic appeal. Trends in the market further contribute to the development of the Ophthalmic Devices market in EMEA. Technological advancements have led to the introduction of cutting-edge devices such as optical coherence tomography (OCT) systems, phacoemulsification systems, and femtosecond lasers. These devices offer improved accuracy, precision, and patient comfort, driving their adoption in the market. Furthermore, there is a growing trend towards minimally invasive surgeries and the use of robotics in ophthalmic procedures, leading to increased efficiency and better patient outcomes. Local special circumstances also impact the growth of the Ophthalmic Devices market in EMEA. Each country within the region has its own unique healthcare infrastructure, regulatory environment, and reimbursement policies. These factors can influence the adoption and accessibility of ophthalmic devices. For example, countries with well-developed healthcare systems and favorable reimbursement policies are likely to have higher adoption rates of advanced ophthalmic devices. On the other hand, countries with limited healthcare resources may face challenges in providing access to these devices to all segments of the population. Underlying macroeconomic factors also contribute to the development of the Ophthalmic Devices market in EMEA. Economic growth, increasing disposable incomes, and improving healthcare infrastructure are key drivers of market growth. As economies in the region continue to develop, there is a greater ability for individuals to afford ophthalmic devices and seek necessary eye care services. Additionally, advancements in healthcare infrastructure and facilities enable better diagnosis and treatment of eye conditions, leading to increased demand for ophthalmic devices. In conclusion, the Ophthalmic Devices market in EMEA is experiencing growth and development due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. The increasing demand for advanced ophthalmic devices, technological advancements, unique local circumstances, and favorable macroeconomic conditions are all contributing to the expansion of the market in the region.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)